Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria...
113 insider purchases on record · latest filing 2023-03-14.
Insiders have also filed 899 sale transactions at NVAX.